Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Futura Launches Eroxon Erectile Dysfunction Gel In Europe, US Launch Delayed Until Q2 2023

Mar 16 2023

• By David Ridley

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

Related Content

Cooper Preparing European Launch Of Eroxon OTC Erectile Dysfunction Gel

Feb 13 2023

Futura All Set For US FDA De Novo Application For Eroxon OTC ED Treatment

Oct 04 2022

Perrigo To Launch UK Private-Label Viagra Connect Competitor

Feb 17 2020

Teva UK Enters Erectile Dysfunction Category With First Ever Rx-To-OTC Switch

Oct 19 2021

Viatris Welcomes ‘Healthy Competition’ For UK OTC Erectile Dysfunction Top Spot

Oct 04 2021

UK Cialis Rx-To-OTC Switch World-First For Sanofi, H2 2023 Launch Planned

Mar 14 2023

Related Companies

Futura Medical plc

Viatris Inc.

Additional Topics

Europe Ad Campaigns Advertising, Marketing & Sales Business Strategies Consumer Deals Distribution E-Commerce Innovation Launches OTC Devices OTC Drugs Regulation Safety StartUps and SMEs FDA Medical Device

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window